You are looking for

The blogosphere has been driven into a foment over the last week or so by a paper by Groeneveld et al entitled ‘Increasing Use of Cardiovascular Devices and Rising Health Costs’. Its conclusions are interesting but, I suggest, not conclusive of anything which should prompt policy makers to ask further questions. Discounted for inflation the […]

Patient safety and public perception: transparency, transparency, transparency…In scanning the disparate output of the EU machine I came across a thought provoking survey of EU citizens on the subject of patient safety. Perception surveys are scientifically questionable as  they deal in the currency of (often poorly informed) individual’s views. Politically and from a policy perspective […]

Like much of the business community I have had plenty of time for thought and reading. A 24 hour trip to Milan has turned into a five day marathon. Both reading and experience have stimulated thoughts about the operation of markets. Firstly, after several hours on Thursday, I managed to secure a hotel room in […]

Talking about ethics and compliance as industry understands it within the frame of a course of Health Systems Management given at the Public Health School of the Université Libre de Bruxelles (ULB) presented itself as a challenge. On the one hand, Eucomed is putting a lot of efforts into promoting a culture of integrity and […]

The prominence of World Kidney Day (11th March) brings into sharp focus the changing epidemiology of our times and the impact of modern life styles of the developed world on the demands placed on healthcare systems. The surge in incidence of diabetes coupled with extending life expectancy are producing a parallel rise in the incidence […]

In recent weeks within the pharmaceutical industry there has been much talk of both downsizing – GSK and AstraZeneca shedding 11,000 jobs – and outsourcing of research and development, with a whole range of licensing or partnership deals designed to pad out faltering product pipelines. Once again I was prompted to think about the prospect […]

It is perhaps surprising how quickly coronary angioplasty has become just another everyday procedure. As someone who has seen open-heart surgery live and witnessed the trauma and hospital resource intensity of such procedures, the placing of a stent as an alternative is almost unimaginably better for both patient and the health sytem as a whole. […]

In an ideal world we would have the same rules on devices in each country.  As patients, as we live or travel in different countries, we can be confident that should we fall ill, the devices used to help us are as safe as the ones at home.  As businesses, we would be confident that […]

On the 29th October all the votes were in and it seems that nothing more than EU paperwork stands between us and our first compulsory European database for medical devices, the infamous ‘Eudamed’ database. I say compulsory because ‘Eudamed’, as our European device database is known, has been in place for many years, but it […]